Broad and narrow personality traits as markers of one-time and repeated suicide attempts: A population-based study

<p>Abstract</p> <p>Background</p> <p>Studying personality traits with the potential to differentiate between individuals engaging in suicide attempts of different degrees of severity could help us to understand the processes underlying the link of personality and nonfatal suicidal behaviours and to identify at-risk groups. One approach may be to examine whether narrow, i.e., lower-order personality traits may be more useful than their underlying, broad personality trait dimensions.</p> <p>Methods</p> <p>We investigated qualitative and quantitative differences in broad and narrow personality traits between one-time and repeated suicide attempters in a longitudinal, population-based sample of young French Canadian adults using two multivariate regression models.</p> <p>Results</p> <p>One broad (Compulsivity: OR = 2.0; 95% CI 1.2–3.5) and one narrow personality trait (anxiousness: OR = 1.1; 95% CI 1.01–1.1) differentiated between individuals with histories of repeated and one-time suicide attempts. Affective instability [(OR = 1.1; 95% CI 1.04–1.1)] and anxiousness [(OR = .92; 95% CI .88–.95)], on the other hand, differentiated between nonattempters and one-time suicide attempters.</p> <p>Conclusion</p> <p>Emotional and cognitive dysregulation and associated behavioural manifestations may be associated with suicide attempts of different severity. While findings associated with narrow traits may be easier to interpret and link to existing sociobiological theories, larger effect sizes associated with broad traits such as Compulsivity may be better suited to objectives with a more clinical focus.</p

Fuel–oxidizer mixtures: their stabilities and burn characteristics

Abstarct A survey of the stability and performance of eleven solid oxidizers and thirteen fuels was performed by differential scanning calorimetry, simultaneous differential thermolysis, and hot-wire ignition. Sugars, alcohols, hydrocarbons, benzoic acid, sulfur, charcoal, and aluminum were used as fuels; all fuels except charcoal and aluminum melted at or below 200 °C. It was found that the reaction between the oxidizer and the fuel was usually triggered by a thermal event, i.e., melt, phase change, or decomposition. Although the fuel usually underwent such a transition at a lower temperature than the oxidizer, the phase change of the fuel was not always the triggering event. When sugars or sulfur were the fuels, their phase change usually triggered their oxidation. However, three oxidizers, KNO3, KClO4, and NH4ClO4, tended to react only after they underwent a phase change or began to decompose, which meant that their oxidization reaction, regardless of the fuel, was usually above 400 °C. KClO4-fuel mixtures decomposed at the highest temperatures, often over 500 °C, with the ammonium salt decomposing almost 100 °C lower. Mixtures with ammonium nitrate (AN) also decomposed at much lower temperatures than those with the corresponding potassium salt. With the exception of the oxidizers triggered to react by the phase changes of the polyols and sulfur, the oxidizer-fuel mixtures generally decomposed between 230 and 300 °C, with AN formulations generally decomposing at the lowest temperature. In terms of heat release, potassium dichromate-fuel mixtures were the least energetic, generally releasing less than 200 J g-1. Most of the mixtures released 1000-1500 J g-1, with potassium chlorate, ammonium perchlorate, and AN releasing significantly more heat, around 2000 J g-1. When the fuel was aluminum, most of the oxidizers decomposed below 500 °C leaving the aluminum to oxidize at over 800 °C. Only two oxidizers reduced the temperature of the aluminum exotherm - chlorate and potassium nitrite. To go to temperatures above 500 °C, unsealed crucibles were necessary, and with these containers, the endothermic volatilization of reactants and products effectively competed against the exothermic decomposition so that heat release values were artificially low

Diagnóstico e estadiamento do câncer de pulmão Diagnosis and staging of lung cancer

O câncer do pulmão pode apresentar-se sob diversas formas e vários são os meios de diagnosticá-lo. A escolha do melhor método para o seu diagnóstico depende de diferentes aspectos relacionados ao tumor, ao paciente e à habilidade da equipe médica. Dentre os métodos mais comumente utilizados para o diagnóstico do câncer do pulmão, podemos contar, além dos exames radiológicos, que não serão abordados neste artigo, a citologia do escarro, a broncofibroscopia, a punção aspirativa transtorácica e a toracoscopia, entre outros. O estadiamento reflete a extensão anatômica do câncer. As regras de estadiamento propostas por Denoix foram adaptadas de maneira satisfatória para o câncer do pulmão e, embora tenham sofrido diversas modificações, devidas ao avanço tecnológico dos métodos de diagnóstico, são importantes para orientar o tratamento e estimar o prognóstico. Com o advento de novas modalidades de tratamento, principalmente as combinadas, o estadiamento tende a assumir importância cada vez maior, tanto na escolha da modalidade terapêutica mais adequada quanto na comparação dos resultados.<br>Carcinoma of the lung can present in a number of guises and a number of possible and often complementary diagnostic approaches are available. The choice of procedure should reflect the presentation of the tumor, local expertise, intended management and patient preference. There are different methods of investigation: sputum cytology, fiberbronchoscopy, transbronchial biopsy, transbronchial needle aspiration, transthoracic fine needle aspiration, etc. The association of all of these methods increases the power of diagnosis. Staging is the measurement of the anatomical extent of a tumor in any given patient. The staging of cancer began with Denoix's TNM classification system, and, although several modifications were developed, it remains the basis of lung cancer staging systems up to now. Assigning patients to a particular TNM stage allows choosing the most appropriate therapy and provides prognostic information. Also, the impact of new therapeutic methods can be evaluated for efficacy and a comparison of the expected survival rates can be predicted